Inhibition of Sympathetic Activation by Delivering Calcium Channel Blockers from a 3D Printed Scaffold to Promote Bone Defect Repair

Shikai Li,Zhihui Li,Jin Yang,Yujie Ha,Xiaojun Zhou,Chuanglong He
DOI: https://doi.org/10.1002/adhm.202200785
IF: 10
2022-06-08
Advanced Healthcare Materials
Abstract:Enhancing osteogenesis by promoting neural network reconstruction and neuropeptide release has been considered to be an attractive strategy for repairing of critical size bone defects. However, traumatic bone defects often activate the damaged sympathetic nervous system in the defect area and release excessive catecholamine to hinder bone defect repair. Herein, we propose a three‐dimensional (3D) printed scaffold loaded with the calcium channel blocker‐nifedipine to reduce the concentration of catecholamine present in the bone defect region and to accelerate bone healing. To this end, nifedipine‐loaded ethosome (NP@Eth) and laponite (Lap) were added into a mixed solution containing sodium alginate (SA), methacrylated gelatin (GelMA) and bone mesenchymal stem cells (BMSCs) to prepare a cell‐laden scaffold (SGL‐NP@Eth) using 3D bioprinting. The released nifedipine is able to close the calcium channels of nerve cells, thereby blocking sympathetic activation and ultimately inhibiting the release of catecholamine by sympathetic nerve cells, which further promoted the osteogenic differentiation and migration of BMSCs, inhibited osteoclastogenesis in vitro, and effectively improved bone regeneration in a rat critical‐size calvarial defect model. Therefore, our results suggest that sustained release of nifedipine from the scaffold can effectively block sympathetic nervous system activation, providing promising strategies for future treatment of bone defects. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?